COMMUNIQUÉS West-GlobeNewswire

Neuralstem Reports Year End 2017 Fiscal Results and Business Update
02/04/2018
- Neuralstem Releases Full Data Set for NSI-189 MDD Trial Showing Patient Rated Outcome and Cognitive Benefits - Nature Medicine Paper Demonstrates Benefit of NSI-566 on Paralysis in Non-Human Primates GERMANTOWN, Md., [...]
Myriad Receives Pre-Market Approval for its BRACAnalysis® Diagnostic System in Japan
02/04/2018
SALT LAKE CITY, April 02, 2018 (GLOBE NEWSWIRE) -- Myriad Genetic Laboratories, Inc., a wholly-owned subsidiary of Myriad Genetics, Inc. (NASDAQ: MYGN ), announced today that the Japanese Ministry of Health, Labour, and [...]
Tetraphase Pharmaceuticals to Present at H.C. Wainwright Annual Global Life Sciences Conference
02/04/2018
WATERTOWN, Mass., April 02, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH ) a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant [...]
Eyenovia Announces Fourth Quarter and Full Year 2017 Financial Results
02/04/2018
NEW YORK, April 02, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN ), a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to [...]
PotNetwork Holding's Diamond CBD Breaks into Untapped African Continent
02/04/2018
FT LAUDERDALE, Fla., April 02, 2018 (GLOBE NEWSWIRE) -- PotNetwork Holding, Inc. (OTC Pink:POTN) On Monday, April 2nd, 2018, PotNetwork Holding Inc.'s wholly owned subsidiary, Diamond CBD Inc. announces plans to kick [...]
MediciNova Announces Phase 2 Trial of MN-001 (tipelukast) in NASH / NAFLD will be Terminated Early based on Significant Positive Results from Interim Analysis
02/04/2018
LA JOLLA, Calif., April 01, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875 [...]
Le Groupe Jean Coutu – Dividende quatrième trimestre de l’exercice financier 2018
01/04/2018
VARENNES, Québec, 01 avr. 2018 (GLOBE NEWSWIRE) -- Le Groupe Jean Coutu (PJC) inc. (la « Société » ou le « Groupe Jean Coutu ») (TSX:PJC.A) annonce que son conseil d’administration a déclaré aujourd’hui un dividende de [...]
Evogene Files Annual Report for the Year Ended December 31, 2017
01/04/2018
REHOVOT, Israel, April 01, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ: EVGN ) (TASE: EVGN ), a leading biotechnology company developing novel products for life science markets through the use of a unique [...]
The Jean Coutu Group – Dividend Fourth Quarter of Fiscal Year 2018
01/04/2018
VARENNES, Québec, April 01, 2018 (GLOBE NEWSWIRE) -- The Jean Coutu Group (PJC) Inc. (the "Corporation" or the "Jean Coutu Group") (TSX:PJC.A) announces that its Board of Directors has declared today a quarterly [...]
Veloxis Announces the Total Number of Shares and Voting Rights in the Company as of 31 March 2018
31/03/2018
Company Release no. 07/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 31 March 2018 Veloxis Announces the Total Number of Shares and Voting Rights in the Company as of 31 March 2018 Veloxis Pharmaceuticals A/S [...]
Novelion Therapeutics Supports World Lipodystrophy Day
31/03/2018
VANCOUVER, British Columbia, March 31, 2018 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN ), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare [...]
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
31/03/2018
CAMBRIDGE, Mass., March 30, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 28 février 2018
30/03/2018
Communiqué de presse Villepinte, le 30 mars 2018 DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l' [...]
TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007
30/03/2018
REGULATED INFORMATION PRESS RELEASE Transparency notifications pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - March 30, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix") [...]
More Than 20 Cerner Executives Earn Board Certification in Health Care Management
30/03/2018
KANSAS CITY, Mo., March 30, 2018 (GLOBE NEWSWIRE) -- Cerner announced that 21 of its associates recently earned the distinction of board certification in health care management as Fellows of the American College of [...]
SteadyMed Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results
30/03/2018
SAN RAMON, Calif., March 30, 2018 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq: STDY ), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and high-value diseases with [...]
Radius Health Initiates Phase 3 Clinical Trial of Abaloparatide Injection for the Treatment of Male Osteoporosis
30/03/2018
WALTHAM, Mass., March 30, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS ) announced today that the company has initiated the Phase 3 ATOM ( A baloparatide T reatment for O steoporosis in M ales) study of [...]
NANOBIOTIX : Nanobiotix 2017 Annual Results
30/03/2018
Nanobiotix 2017 Annual Results Paris, France and Cambridge, Massachusetts, USA, March 30, 2018 - NANOBIOTIX (Euronext: NANO - ISIN: FR0011341205), a late clinical-stage nanomedicine company pioneering new approaches to [...]
NANOBIOTIX : Nanobiotix : Résultats Annuels 2017
30/03/2018
Nanobiotix : Résultats Annuels 2017 Paris, France, et Cambridge, Massachusetts (USA) le 30 mars 2018 - NANOBIOTIX (Euronext: NANO - ISIN: FR0011341205), société française pionnière en nanomédecine développant de [...]

Pages